NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
2.790
+0.250 (9.84%)
At close: Jun 27, 2025, 4:00 PM
2.850
+0.060 (2.15%)
After-hours: Jun 27, 2025, 7:59 PM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $8.82 million as of June 27, 2025. Its market cap has increased by 78.10% in one year.
Market Cap
8.82M
Enterprise Value
7.15M
1-Year Change
78.10%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $8.82M, a decrease of -56.18%. That is a compound annual growth rate of -17.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 8.03M | 134.45% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |